- Home
- LMND vs RLAY Comparison
LMND vs RLAY Comparison
Compare LMND & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LMND | RLAY |
|---|---|---|
| Founded | 2015 | 2015 |
| Country | United States | United States |
| Employees | 1282 | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 4.1B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | LMND | RLAY |
|---|---|---|
| Price | $66.05 | $19.51 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 10 |
| Target Price | ★ $70.86 | $19.50 |
| AVG Volume (30 Days) | 1.4M | ★ 4.2M |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 31.78 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $15,355,000.00 |
| Revenue This Year | $65.20 | N/A |
| Revenue Next Year | $33.31 | $324.03 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 53.44 |
| 52 Week Low | $35.70 | $3.03 |
| 52 Week High | $99.90 | $20.79 |
Technical Indicators
Market Signals| Indicator | LMND | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 51.24 | 60.41 |
| Support Level | $64.05 | $12.10 |
| Resistance Level | $72.31 | $20.79 |
| Average True Range (ATR) | 4.23 | 1.23 |
| MACD | -0.45 | -0.10 |
| Stochastic Oscillator | 39.40 | 57.26 |
Price Performance
Historical ComparisonAbout LMND Lemonade Inc.
Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes. The company is using technology, data, artificial intelligence, contemporary design, and social impact to deliver delightful and affordable insurances. The Company operates in one report segment providing personal property and casualty insurance products within the United States and Europe, including the UK.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.